About Nellix
Nellix is a company based in Palo Alto (United States) founded in 1994 was acquired by Endologix in October 2010. Nellix has raised $18.2 million across 3 funding rounds from investors including Endologix, Incept BioSystems and EW Healthcare Partners. Nellix operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
- Headquarter Palo Alto, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nellix Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nellix
Nellix has successfully raised a total of $18.2M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $11.7 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nellix
Nellix has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Endologix, Incept BioSystems and EW Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Locked | Locked | Locked | |
|
Medical innovations are accelerated from concept to commercialization by Incept.
|
Locked | Locked | Locked | |
|
IVF technologies for embryo and oocyte culture are provided.
|
Locked | Locked | Locked |
Investor details for Nellix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nellix
Investment portfolio details for Nellix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nellix
Detailed financials for Nellix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nellix Comparisons
Peer comparison for Nellix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nellix
Nellix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| Locked | Locked | Locked |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| Locked | Locked | Locked |
Designs and manufactures for endovascular aortic repair equipment
|
|
| Locked | Locked | Locked |
Endovascular devices for aortic aneurysms are developed.
|
|
| Locked | Locked | Locked |
Endograft anchoring systems for aortic aneurysms are developed.
|
|
| Locked | Locked | Locked |
Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics.
|
Detailed competitors of Nellix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nellix
Complete news archive for Nellix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nellix
Nellix was founded in 1994 and raised its 1st funding round 6 years after it was founded.
Nellix is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Nellix is a funded company, having raised a total of $18.2M across 3 funding rounds to date.
Nellix was founded in 1994 in Palo Alto, United States, within the medical device sector. A specialized endograft and low-profile delivery system have been developed to enable treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. These devices support expanded indications for minimally invasive procedures, addressing aneurysms through endovascular methods. Operations focus on innovation in vascular treatments for clinical applications.
Nellix's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Nellix has 4 investors. Key investors include Endologix, Incept BioSystems, EW Healthcare Partners, and Incept.